2018
Overview
Drug resistance mechanisms refer to the biological processes by which pathogens, cancer cells, or other disease-causing agents develop the ability to survive and proliferate despite exposure to therapeutic drugs that were initially effective against them. Research published in the International Journal of Chemotherapy Research and Practice examines these mechanisms within the broader context of chemotherapeutic interventions and clinical practice. The journal provides a platform for investigations into how resistance emerges and evolves, affecting treatment outcomes across various disease states. Understanding drug resistance mechanisms is critical because resistance remains a major obstacle to successful long-term therapy in oncology, infectious diseases, and other medical fields. When cells or organisms develop resistance, previously effective treatments lose their potency, leading to treatment failure, disease progression, and the need for alternative or combination therapeutic strategies. The journal's scope encompasses both fundamental research into the molecular and cellular basis of resistance as well as practical clinical considerations for managing resistant cases. By publishing work in this area, the journal contributes to the scientific foundation needed to anticipate, detect, and potentially overcome resistance, ultimately supporting improved patient outcomes and more durable therapeutic responses.
Research published in this journal
1 peer-reviewed article, ranked by relevance. Each links to its DOI.